Pretraživanje
Prikaz rezultata 1-7 od 7
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Influence of microenvironmental conditions on hybridoma cell growth inside the alginate-poly-L-lysine microcapsule
(Elsevier Sci Ltd, Oxford, 2007)
A mathematical model was formulated to describe hybridoma cell growth within the alginate-poly-L-lysine (alginate-PLL) microcapsules during air-lift bioreactor cultivation. Model development was based on experimentally ...
Training and capacity building in central and eastern Europe through the EuroFIR and CEE networks
(Elsevier Sci Ltd, Oxford, 2009)
Capacity building in food and nutrition aims to enhance knowledge and support infrastructural development in this field. International Network of Food Data Systems (INFOODS) was established on the basis of the recommendations ...
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
Methods of assessment of iodine status in humans: a systematic review
(Oxford Univ Press, Oxford, 2009)
Background: Biomarkers of iodine status are required to study iodine deficiency disorders in different parts of the world and to evaluate the effects of fortification strategies. Objective: The objective was to assess the ...